#34 Biomarkers of aging: How close are we, really? - A conversation with Sara Hägg
LEVITY28 Okt 2025

#34 Biomarkers of aging: How close are we, really? - A conversation with Sara Hägg

Sara Hägg, PhD is an associate professor at Karolinska Institutet, where she leads the Molecular Epidemiology of Aging Group. Her work focuses on human biomarkers of aging - especially biological age “clocks” built from epigenetic, proteomic, and metabolomic data - and on turning Nordic registry resources into clinically useful aging measures.


In this episode:

* What biological/epigenetic age clocks actually measure (and what they don’t)

* Accuracy, error bars, and why clocks aren’t clinic-ready yet

* Epigenetic vs. proteomic vs. metabolomic clocks - strengths and trade-offs

* Organ-specific clocks (liver, ovary, kidney) and what they reveal

* Why uncertainty spikes at life transitions; menopause as a natural “stress test”

* PC (principal-component) clocks and noise reduction

* Nordic registry & Swedish Twin Registry advantages; UK Biobank use

* Direct-to-consumer tests: interpreting results and common pitfalls

* AI’s role in building/validating clocks and handling uncertainty

* What would move the field fastest (data, standards, trials) and where Sweden stands


Show notes for this episode will be available after this airs. Sign up for the LEVITY newsletter to get them straight to your inbox: reachlevity.com


LEVITY is co-hosted by Patrick Linden, philosopher and author, and Peter Ottsjö, journalist and author.


CHAPTERS

00:00 Introduction

03:27 Why Sweden lags behind in longevity science

08:04 Nordic registry & Swedish twin registry advantages; UK Biobank use

10:05 What is biological age?

16:33 The rise of epigenetic clocks

24:22 The importance of aging clocks

32:04 Beyond methylation: proteomic and metabolomic clocks

35:12 Organ clocks

39:37 Do aging clocks generalize?

54:37 The cost of aging clocks

01:03:18 Uncertainty and AI

01:17:10 Solving aging - where do we stand?

01:28:10 Book recommendations

🗞️ SUBSCRIBE to the LEVITY newsletter: reachlevity.com/subscribe

Get all LEVITY DeSci content here: reachlevity.com/t/desci (sorry about the wrong link in the episode)


📕 Check out Patrick's book: https://mitpress.mit.edu/9780262543163/the-case-against-death/

📗 Check out Peter's book (only available in Swedish): https://www.adlibris.com/sv/bok/evigt-ung-min-och-manniskans-drom-om-ododligheten-9789179652524


-----


Show notes for this episode will be available soon after this airs. Sign up for the LEVITY newsletter to get them straight to your inbox: reachlevity.com/subscribe


LEVITY is co-hosted by Patrick Linden, philosopher and author, and Peter Ottsjö, journalist and author.

Hosted on Acast. See acast.com/privacy for more information.

Episoder(39)

#37 The Anti-Catastrophe League

#37 The Anti-Catastrophe League

Tom Ough tells us about the Big Things that may end humanity - and what we can do and in some cases have done to prevent these. Did you know that if all the risks, the one that is most likely to end y...

16 Des 202544min

#36 How crypto is sparking a longevity frenzy

#36 How crypto is sparking a longevity frenzy

Today we’re diving into one of the strangest and most ambitious ideas in longevity: using crypto trading to fund real-time lifespan experiments.Benji Leibowitz, founder of pump.science, joins us to ex...

2 Des 20251h 48min

#35 The Anti-Aging Uprising: Felix Werth’s Political Attack on Death Itself

#35 The Anti-Aging Uprising: Felix Werth’s Political Attack on Death Itself

Valuable time is being lost because there is not enough funding for science with real life-extending potential. No major political party is promising to address aging, even though aging harms and kill...

11 Nov 20251h 24min

#33 “Can death be the answer?"  A conversation with philosopher Nicholas Agar

#33 “Can death be the answer?" A conversation with philosopher Nicholas Agar

We are always excited about the next technological solution. But what if it does not come? Or what if it comes only for the few, or with terrible side-effects? And while we are waiting for the easy te...

7 Okt 20251h 44min

#32 “Medical malpractice”: Matt Kaeberlein on biological age tests

#32 “Medical malpractice”: Matt Kaeberlein on biological age tests

One idea I’ve had lately is to put together a list of people to trust in geroscience and the longevity field more broadly. (And I might do it - keep an eye on reachlevity.com- and subscribe while you’...

23 Sep 20251h 50min

# 31 He wants to save your pet with cryo - The Kai Micah Mills interview

# 31 He wants to save your pet with cryo - The Kai Micah Mills interview

When you give a child a pet, you also expose them to death—since most pets pass away long before their owners. But what if we could cryopreserve Buddy or Tiger, and bring them back from suspended anim...

9 Sep 20252h 8min

#30 Soon you'll take a drug designed by AI  | Alex Zhavoronkov

#30 Soon you'll take a drug designed by AI | Alex Zhavoronkov

As you may have heard, AI-designed medicines have crossed a historic line. In this episode, Alex Zhavoronkov - CEO of Insilico Medicine and founder of ARDD walks us through how Insilico’s rentosertib ...

26 Aug 20252h 13min

Populært innen Vitenskap

fastlegen
rekommandert
tingenes-tilstand
jss
forskningno
sinnsyn
liberal-halvtime
rss-rekommandert
tomprat-med-gunnar-tjomlid
smart-forklart
rss-paradigmepodden
villmarksliv
fjellsportpodden
tidlose-historier
dekodet-2
vett-og-vitenskap-med-gaute-einevoll
nordnorsk-historie
diagnose
abid-nadia-skyld-og-skam
rss-overskuddsliv